Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer’s disease

[1]  Hong-Lei Li,et al.  The polymorphism of the ATP-binding cassette transporter 1 gene modulates Alzheimer disease risk in Chinese Han ethnic population. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[2]  B. Platt,et al.  Susceptibility to diet-induced obesity and glucose intolerance in the APPSWE/PSEN1A246E mouse model of Alzheimer’s disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein , 2011, Diabetologia.

[3]  M. Karimloo,et al.  The Association between Sporadic Alzheimer’s Disease and the Human ABCA1 and APOE Gene Polymorphisms in Iranian Population , 2011, Iranian Red Crescent medical journal.

[4]  B. Cheung,et al.  A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[5]  S. DeKosky,et al.  Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease , 2007, Neurobiology of Aging.

[6]  J. Jia,et al.  Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese , 2007, Brain Research.

[7]  F. Jessen,et al.  Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. , 2006, International journal of molecular medicine.

[8]  R. Mayeux,et al.  Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease , 2006, Neuroscience Letters.

[9]  B. Nordestgaard,et al.  Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. , 2004, The Journal of clinical investigation.

[10]  L. Bernier,et al.  Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain* , 2004, Journal of Biological Chemistry.

[11]  Steven J. Schrodi,et al.  Association of ABCA1 with late-onset Alzheimer’s disease is not observed in a case-control study , 2004, Neuroscience Letters.

[12]  J. Palmgren,et al.  Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β‐amyloid metabolism , 2004, Human mutation.

[13]  R. Nitsch,et al.  ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer’s disease , 2003, Neurobiology of Aging.

[14]  P. Yancey,et al.  Importance of different pathways of cellular cholesterol efflux. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Freeman,et al.  Naturally Occurring Mutations in the Largest Extracellular Loops of ABCA1 Can Disrupt Its Direct Interaction with Apolipoprotein A-I* , 2002, The Journal of Biological Chemistry.

[16]  T. Hudson,et al.  Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease , 2001, Circulation.

[17]  G. Schmitz,et al.  ABC transporters in cellular lipid trafficking , 2000, Current opinion in lipidology.

[18]  R. Tanzi,et al.  A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. , 1999, The Journal of clinical investigation.

[19]  J. Piette,et al.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.

[20]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[21]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[22]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[23]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[25]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[26]  B. Woolf.  ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.

[27]  O. Combarros,et al.  Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer's disease risk. , 2010, Journal of Alzheimer's disease : JAD.

[28]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[29]  Edu,et al.  Molecular Neurodegeneration Apolipoprotein E Levels in Cerebrospinal Fluid and the Effects of Abca1 Polymorphisms , 2022 .